Program

Thursday, 20 February 2025

12.00	Registration
13.00	Welcome
13.15	Keynote The role of LTX in metabolic disease Carlo Dionisi-Vici (Rome)
13.45	Longterm outcome after liver transplantation - Part 1 Post-LTX metabolism in MMA and other organic aciduria Diego Martinelli (Rome) Longterm outcome after LTX incl. quality of life Martina Sterneck, Louisa Lund (Hamburg)
14.45	Longterm outcome after liver transplantation - Part 2
	Longterm cancer risk under immuno- suppression Wilhelm Wößmann (Hamburg) Transition in care: balancing between evidence and good care Anneloes van Staa (Rotterdam)
15.45	Coffee Break \| Industry Exhibition
16.15	IPSEN Industry symposium Every baby deserves a genetic screening? Malin Fromme (Aachen) & Irina Hüning (Lübeck)
16.45	Hepatobiliary surgery & interventions Intraoperative bile duct imaging Ricardo Superina (Chicago) to be announced
18.00	End of the day
19.00	Congress dinner

08.30	Welcome
08.45	Keynote
	Biliary atresia Claus Petersen (Hanover)
09.15	BARD Session on biliary atresia Podium discussion on when to go for transplantation Ricardo Superina (Chicago), Mark Davenport (London)
10.00	Coffee Break \| Industry Exhibition
10.30	The hepatologists‘ view on biliary atresia Henkjan Verkade (Groningen)
11.00	20 years national centralization of BA care Mikko Pakarinen (Helsinki)
11.30	MIRUM Industry symposium Unveiling the hidden signals: Biomarkers and symptoms in neonatal cholestasis André Hörning (Erlangen) & Thomas Kaiser (Münster)
12.30	Lunch Break \| Industry Exhibition
13.15	Wilson‘s disease
	New diagnostic tools and therapeutic innovation Isabelle Mohr (Heidelberg)
	Pediatric acute liver failure in Wilson's Disease Piotr Socha (Warsaw)
14.15	Hepatology & genetics
	Genetic markers and their prognostic significance in PFIC Henkjan Verkade (Groningen)
14.45	ERN activities and registries ERN Rare Liver ERN Transplant Child MetabERN
15.30	Farewell